from Reuters: Health News https://ift.tt/2lSdPlD
Thursday, July 5, 2018
Thursday, July 05, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
(Reuters Health) - Many breast cancer patients may miss out on genetic tests that could help pinpoint the ideal treatment regimen at least in part because their surgeons are uncomfortable discussing the pros and cons of these tests, a U.S. study suggests.

from Reuters: Health News https://ift.tt/2lSdPlD
from Reuters: Health News https://ift.tt/2lSdPlD
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment